Rizkallah, J.; Charbel, N.; Yassine, A.; El Masri, A.; Raffoul, C.; El Sardouk, O.; Ghezzawi, M.; Abou Nasr, T.; Kreidieh, F.
Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future Perspectives. Pharmaceutics 2025, 17, 1019.
https://doi.org/10.3390/pharmaceutics17081019
AMA Style
Rizkallah J, Charbel N, Yassine A, El Masri A, Raffoul C, El Sardouk O, Ghezzawi M, Abou Nasr T, Kreidieh F.
Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future Perspectives. Pharmaceutics. 2025; 17(8):1019.
https://doi.org/10.3390/pharmaceutics17081019
Chicago/Turabian Style
Rizkallah, Joe, Nicole Charbel, Abdallah Yassine, Amal El Masri, Chris Raffoul, Omar El Sardouk, Malak Ghezzawi, Therese Abou Nasr, and Firas Kreidieh.
2025. "Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future Perspectives" Pharmaceutics 17, no. 8: 1019.
https://doi.org/10.3390/pharmaceutics17081019
APA Style
Rizkallah, J., Charbel, N., Yassine, A., El Masri, A., Raffoul, C., El Sardouk, O., Ghezzawi, M., Abou Nasr, T., & Kreidieh, F.
(2025). Melittin-Based Nanoparticles for Cancer Therapy: Mechanisms, Applications, and Future Perspectives. Pharmaceutics, 17(8), 1019.
https://doi.org/10.3390/pharmaceutics17081019
